ANI Pharmaceuticals
ANIP
#5255
Rank
S$2.00 B
Marketcap
S$88.43
Share price
-0.84%
Change (1 day)
-15.80%
Change (1 year)

EPS for ANI Pharmaceuticals (ANIP)

EPS in 2026 (TTM): S$6.65

According to ANI Pharmaceuticals's latest financial reports the company's current EPS (TTM) is S$6.68. In 2025 the company made an earnings per share (EPS) of S$4.51 an increase over its 2024 EPS that were of S-$1.44.

EPS history for ANI Pharmaceuticals from 2013 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S$6.6547.36%
2025S$4.51-412.5%
2024S-$1.44
2022S-$3.92-6.46%
2021S-$4.1972.87%
2020S-$2.43-476%
2019S$0.64-62.12%
2018S$1.70
2015S$1.73-47.66%
2014S$3.30-142.11%
2013S-$7.84

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
S$6.77 1.35%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
S$0.92-86.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Cardinal Health
CAH
S$10.01 49.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Jazz Pharmaceuticals
JAZZ
S$4.68-29.92%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Evoke Pharma
EVOK
S-$3.25-148.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
S-$5.61-183.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
S$0.58-91.31%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Royalty Pharma
RPRX
S$1.97-70.48%๐Ÿ‡ฌ๐Ÿ‡ง UK
Lannett Company
LCI
S-$32.61-588.03%๐Ÿ‡บ๐Ÿ‡ธ USA